An evaluation of continuous subcutaneous infusions across seven NHS acute hospitals: is there potential for 48-hour infusions?

BACKGROUND: Continuous subcutaneous infusions (CSCIs) are commonly used in the United Kingdom as a way of administering medication to patients requiring symptom control when the oral route is compromised. These infusions are typically administered over 24 h due to currently available safety data. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Baker, J., Dickman, A., Mason, S., Bickerstaff, M., Jackson, R., McArdle, A., Lawrence, I., Stephenson, F., Paton, N., Kirk, J., Waters, B., Ellershaw, J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7341565/
https://www.ncbi.nlm.nih.gov/pubmed/32635902
http://dx.doi.org/10.1186/s12904-020-00611-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7341565/
https://www.ncbi.nlm.nih.gov/pubmed/32635902
http://dx.doi.org/10.1186/s12904-020-00611-3

Ejemplares similares